Advertisement

Tumors of the Ear and Temporal Bone

  • Juan C. Hernandez-Prera
  • Bruce M. WenigEmail author
Chapter
  • 621 Downloads

Abstract

This chapter focuses on tumors that are unique to and that are primarily localized to the three compartments of the ear. In addition, due to overlapping symptomatology as well as radiological features, tumors from the middle ear and the inner ear are grouped together.

Keywords

Tumors External ear tumors Temporal bone tumors Auditory canal tumors 

References

  1. 1.
    Presutti L, Nogueira JF, Alicandri-Ciufelli M, Marchioni D. Beyond the middle ear: endoscopic surgical anatomy and approaches to inner ear and lateral skull base. Otolaryngol Clin N Am. 2013;46:189–200.Google Scholar
  2. 2.
    Luers JC, Huttenbrink KB. Surgical anatomy and pathology of the middle ear. J Anat. 2016;228:338–53.PubMedGoogle Scholar
  3. 3.
    Kelly KE, Mohs DC. The external auditory canal. Anatomy and physiology. Otolaryngol Clin N Am. 1996;29:725–39.Google Scholar
  4. 4.
    Ozturkcan S, Ozturkcan S. Dermatologic diseases of the external ear. Clin Dermatol. 2014;32:141–52.PubMedGoogle Scholar
  5. 5.
    Mills SE, Stelow E, Hunt JL. Tumors of the ear. In: Silverberg SG, ed. Tumors of the upper aerodigestive tract and ear, AFIP Atlas of Tumor Pathology. Fourth series. American Registry of Pathology; Silver Spring, MD; 2012. p. 517–22.Google Scholar
  6. 6.
    Wolf BA, Gluckman JL, Wirman JA. Benign dermal cylindroma of the external auditory canal: a clinicopathological report. Am J Otolaryngol. 1985;6:35–8.PubMedGoogle Scholar
  7. 7.
    Wetli CV, Pardo V, Millard M, Gerston K. Tumors of ceruminous glands. Cancer. 1972;29:1169–78.PubMedGoogle Scholar
  8. 8.
    Thompson LD, Nelson BL, Barnes EL. Ceruminous adenomas: a clinicopathologic study of 41 cases with a review of the literature. Am J Surg Pathol. 2004;28:308–18.PubMedGoogle Scholar
  9. 9.
    Pulec JL. Glandular tumors of the external auditory canal. Laryngoscope. 1977;87:1601–12.PubMedGoogle Scholar
  10. 10.
    Schenk P, Handisurya A, Steurer M. Ultrastructural morphology of a middle ear ceruminoma. ORL; journal for oto-rhino-laryngology and its related specialties. 2002;64:358–63.PubMedGoogle Scholar
  11. 11.
    Markou K, Karasmanis I, Vlachtsis K, Petridis D, Nikolaou A, Vital V. Primary pleomorphic adenoma of the external ear canal. Report of a case and literature review. Am J Otolaryngol. 2008;29:142–6.PubMedGoogle Scholar
  12. 12.
    Mammino JJ, Vidmar DA. Syringocystadenoma papilliferum. Int J Dermatol. 1991;30:763–6.PubMedGoogle Scholar
  13. 13.
    Lott Limbach AA, Hoschar AP, Thompson LD, Stelow EB, Chute DJ. Middle ear adenomas stain for two cell populations and lack myoepithelial cell differentiation. Head Neck Pathol. 2012;6:345–53.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Torske KR, Thompson LD. Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol. 2002;15:543–55.PubMedGoogle Scholar
  15. 15.
    Sandison A, Stenman G, Thompson LD. Ceruminous gland adenocarcinoma. In: El-Naggar AKCJ, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC Press; 2017. p. 264.Google Scholar
  16. 16.
    Perzin KH, Gullane P, Conley J. Adenoid cystic carcinoma involving the external auditory canal. A clinicopathologic study of 16 cases. Cancer. 1982;50:2873–83.PubMedGoogle Scholar
  17. 17.
    Hicks GW. Tumors arising from the glandular structures of the external auditory canal. Laryngoscope. 1983;93:326–40.PubMedGoogle Scholar
  18. 18.
    Ferlito A, Devaney KO, Rinaldo A, et al. Clinicopathological consultation. Ear cholesteatoma versus cholesterol granuloma. Ann Otol Rhinol Laryngol. 1997;106:79–85.PubMedGoogle Scholar
  19. 19.
    Michaels L. Pathology of cholesteatoma: a review. J R Soc Med. 1979;72:366–9.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Schechter G. A review of cholesteatoma pathology. Laryngoscope. 1969;79:1907–20.PubMedGoogle Scholar
  21. 21.
    Wenig BM, Michaels LM. The ear and temporal bone. In: Mills SE, editor. Histology for pathologists. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 399–432.Google Scholar
  22. 22.
    Kuo CL, Shiao AS, Yung M, et al. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int. 2015;2015:854024.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Schuknecht HF. Cholesteatoma. In: Schuknecht HF, editor. Pathology of the ear. 2nd ed. Philadelphia: Lea & Febiger; 1993. p. 204–6.Google Scholar
  24. 24.
    Kuo CL, Liao WH, Shiao AS. A review of current progress in acquired cholesteatoma management. Eur Arch Otorhinolaryngol. 2015;272:3601–9.PubMedGoogle Scholar
  25. 25.
    Wittmaack K. Wie entsteht ein genuines Cholesteatom? Arch Ohren Nasen Kehlkopfheilkd. 1933;137:306–32.Google Scholar
  26. 26.
    Sudhoff H, Tos M. Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory. Am J Otol. 2000;21:786–92.PubMedGoogle Scholar
  27. 27.
    Michaels L. An epidermoid formation in the developing middle ear: possible source of cholesteatoma. J Otolaryngol. 1986;15:169–74.PubMedGoogle Scholar
  28. 28.
    Abramson M, Moriyama H, Huang CC. Histology, pathogenesis, and treatment of cholesteatoma. Ann Otol Rhinol Laryngol Suppl. 1984;112:125–8.PubMedGoogle Scholar
  29. 29.
    Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope. 2015;125:234–40.PubMedGoogle Scholar
  30. 30.
    Liu W, Yin T, Ren J, et al. Activation of the EGFR/Akt/NF-kappaB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium. Eur Arch Otorhinolaryngol. 2014;271:265–73.PubMedGoogle Scholar
  31. 31.
    Ergun S, Zheng X, Carlsoo B. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma. Am J Otol. 1996;17:393–6.PubMedGoogle Scholar
  32. 32.
    Jin BJ, Min HJ, Jeong JH, Park CW, Lee SH. Expression of EGFR and microvessel density in middle ear cholesteatoma. Clin Exp Otorhinolaryngol. 2011;4:67–71.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Persaud RA, Hajioff D, Thevasagayam MS, Wareing MJ, Wright A. Keratosis obturans and external ear canal cholesteatoma: how and why we should distinguish between these conditions. Clin Otolaryngol Allied Sci. 2004;29:577–81.PubMedGoogle Scholar
  34. 34.
    Kazahaya K, Potsic WP. Congenital cholesteatoma. Curr Opin Otolaryngol Head Neck Surg. 2004;12:398–403.PubMedGoogle Scholar
  35. 35.
    Persaud R, Hajioff D, Trinidade A, et al. Evidence-based review of aetiopathogenic theories of congenital and acquired cholesteatoma. J Laryngol Otol. 2007;121:1013–9.PubMedGoogle Scholar
  36. 36.
    Piepergerdes MC, Kramer BM, Behnke EE. Keratosis obturans and external auditory canal cholesteatoma. Laryngoscope. 1980;90:383–91.PubMedGoogle Scholar
  37. 37.
    Wenig BM. Middle ear adenoma. In: Wenig BM, editor. Atlas of head and neck pathology. 3rd ed. Philadelphia: Elsevier; 2016. p. 1139–44.Google Scholar
  38. 38.
    Hyams VJ, Batsakis JG, Michaels L. Neoplasms of the middle ear. In: Hartmann W, Sobin LS, editors. Tumors of the upper respiratory tract and ear, Second series ed. Washington, DC: Armed Forces Institute of Pathology; 1986. p. 306–30.Google Scholar
  39. 39.
    Sandison A, Bell D, Thompson LD. Middel ear adenoma. In: CJ E-NAK, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC Press; 2017. p. 272–3.Google Scholar
  40. 40.
    Duderstadt M, Forster C, Welkoborsky HJ, Ostertag H. Adenomatous tumors of the middle ear and temporal bone: clinical, morphological and tumor biological characteristics of challenging neoplastic lesions. Eur Arch Otorhinolaryngol. 2012;269:823–31.PubMedGoogle Scholar
  41. 41.
    Saliba I, Evrard A-S. Middle ear glandular neoplasms: adenoma, carcinoma or adenoma with neuroendocrine differentiation: a case series. Cases J. 2009;2:6508.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Ferlito A, Devaney KO, Rinaldo A. Primary carcinoid tumor of the middle ear: a potentially metastasizing tumor. Acta Otolaryngol. 2006;126:228–31.PubMedGoogle Scholar
  43. 43.
    Ramsey MJ, Nadol JB Jr, Pilch BZ, McKenna MJ. Carcinoid tumor of the middle ear: clinical features, recurrences, and metastases. Laryngoscope. 2005;115:1660–6.PubMedGoogle Scholar
  44. 44.
    Fundakowski CE, Chapman JR, Thomas G. Middle ear carcinoid with distant osseous metastasis. Laryngoscope. 2013;123:779–82.PubMedGoogle Scholar
  45. 45.
    Mooney EE, Dodd LG, Oury TD, Burchette JL, Layfield LJ, Scher RL. Middle ear carcinoid: an indolent tumor with metastatic potential. Head Neck. 1999;21:72–7.PubMedGoogle Scholar
  46. 46.
    Bell D, El-Naggar AK, Gidley PW. Middle ear adenomatous neuroendocrine tumors: a 25-year experience at MD Anderson Cancer Center. Virchows Arch. 2017;471:667–72.PubMedGoogle Scholar
  47. 47.
    Hale RJ, McMahon RF, Whittaker JS. Middle ear adenoma: tumour of mixed mucinous and neuroendocrine differentiation. J Clin Pathol. 1991;44:652–4.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Wassef M, Kanavaros P, Polivka M, et al. Middle ear adenoma. A tumor displaying mucinous and neuroendocrine differentiation. Am J Surg Pathol. 1989;13:838–47.PubMedGoogle Scholar
  49. 49.
    Faverly DR, Manni JJ, Smedts F, Verhofstad AA, van Haelst UJ. Adeno-carcinoid or amphicrine tumors of the middle ear a new entity? Pathol Res Pract. 1992;188:162–71.PubMedGoogle Scholar
  50. 50.
    Manni JJ, Faverly DR, Van Haelst UJ. Primary carcinoid tumors of the middle ear. Report on four cases and a review of the literature. Arch Otolaryngol Head Neck Surg. 1992;118:1341–7.PubMedGoogle Scholar
  51. 51.
    Latif MA, Madders DJ, Barton RP, Shaw PA. Carcinoid tumour of the middle ear associated with systemic symptoms. J Laryngol Otol. 1987;101:480–6.PubMedGoogle Scholar
  52. 52.
    Stanley MW, Horwitz CA, Levinson RM, Sibley RK. Carcinoid tumors of the middle ear. Am J Clin Pathol. 1987;87:592–600.PubMedGoogle Scholar
  53. 53.
    Batsakis JG. Adenomatous tumors of the middle ear. Ann Otol Rhinol Laryngol. 1989;98:749–52.PubMedGoogle Scholar
  54. 54.
    Devaney KO, Ferlito A, Rinaldo A. Epithelial tumors of the middle ear – are middle ear carcinoids really distinct from middle ear adenomas? Acta Otolaryngol. 2003;123:678–82.PubMedGoogle Scholar
  55. 55.
    el-Naggar AK, Pflatz M, Ordonez NG, Batsakis JG. Tumors of the middle ear and endolymphatic sac. Pathol Annu. 1994;29(Pt 2):199–231.PubMedGoogle Scholar
  56. 56.
    Williams MD. Paragangliomas of the head and neck: an overview from diagnosis to genetics. Head Neck Pathol. 2017;11:278–87.PubMedPubMedCentralGoogle Scholar
  57. 57.
    Smith JD, Harvey RN, Darr OA, et al. Head and neck paragangliomas: a two-decade institutional experience and algorithm for management. Laryngoscope Investig Otolaryngol. 2017;2:380–9.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Carlson ML, Sweeney AD, Pelosi S, Wanna GB, Glasscock ME 3rd, Haynes DS. Glomus tympanicum: a review of 115 cases over 4 decades. Otolaryngol Head Neck Surg. 2015;152:136–42.PubMedGoogle Scholar
  59. 59.
    Lenders JWM, Duh Q-Y, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metabol. 2014;99:1915–42.Google Scholar
  60. 60.
    Larson TC 3rd, Reese DF, Baker HL Jr, McDonald TJ. Glomus tympanicum chemodectomas: radiographic and clinical characteristics. Radiology. 1987;163:801–6.PubMedGoogle Scholar
  61. 61.
    Szymanska A, Szymanski M, Czekajska-Chehab E, Golabek W, Szczerbo-Trojanowska M. Diagnosis and management of multiple paragangliomas of the head and neck. Eur Arch Otorhinolaryngol. 2015;272:1991–9.PubMedGoogle Scholar
  62. 62.
    Woolen S, Gemmete JJ. Paragangliomas of the head and neck. Neuroimaging Clin N Am. 2016;26:259–78.PubMedGoogle Scholar
  63. 63.
    Olsen WL, Dillon WP, Kelly WM, Norman D, Brant-Zawadzki M, Newton TH. MR imaging of paragangliomas. AJR Am J Roentgenol. 1987;148:201–4.PubMedGoogle Scholar
  64. 64.
    Fishbein L, Nathanson KL. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genet. 2012;205:1–11.PubMedPubMedCentralGoogle Scholar
  65. 65.
    Tischler AS, de Kriger RR, Gill A, et al. Tumors of the adrenal medulla and extra-adrenal paraganglia. In: Lloyd RV, Osamura RY, Klopple G, Rosai J, editors. WHO classification of tumours of endocrine organs. 4th ed. Lyon: IARC Press; 2017. p. 181.Google Scholar
  66. 66.
    Piccini V, Rapizzi E, Bacca A, et al. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients. Endocr Relat Cancer. 2012;19:149–55.PubMedGoogle Scholar
  67. 67.
    Kantorovich V, King KS, Pacak K. SDH-related pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2010;24:415–24.PubMedPubMedCentralGoogle Scholar
  68. 68.
    Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med. 2009;266:19–42.PubMedGoogle Scholar
  69. 69.
    Burnichon N, Rohmer V, Amar L, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metabol. 2009;94:2817–27.Google Scholar
  70. 70.
    Manolidis S, Shohet JA, Jackson CG, Glasscock ME 3rd. Malignant glomus tumors. Laryngoscope. 1999;109:30–4.PubMedGoogle Scholar
  71. 71.
    Benn DE, Robinson BG, Clifton-Bligh RJ. 15 years of paraganglioma: clinical manifestations of paraganglioma syndromes types 1–5. Endocr Relat Cancer. 2015;22:T91–T103.PubMedPubMedCentralGoogle Scholar
  72. 72.
    Manolides S, Hu KS, Persky MS. Paragangliomas of the head and neck. In: Harrison LB, Sessions RB, Kies MS, editors. Head and neck cancer a multidisciplinary approach. 4th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2014.Google Scholar
  73. 73.
    Young NM, Wiet RJ, Russell EJ, Monsell EM. Superselective embolization of glomus jugulare tumors. Ann Otol Rhinol Laryngol. 1988;97:613–20.Google Scholar
  74. 74.
    Hu K, Persky MS. Treatment of head and neck paragangliomas. Cancer Control. 2016;23:228–41.Google Scholar
  75. 75.
    Plaza JA, Wakely PE Jr, Moran C, Fletcher CD, Suster S. Sclerosing paraganglioma: report of 19 cases of an unusual variant of neuroendocrine tumor that may be mistaken for an aggressive malignant neoplasm. Am J Surg Pathol. 2006;30:7–12.PubMedGoogle Scholar
  76. 76.
    Kimura N, Miura Y, Nagatsu I, Nagura H. Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Pathol Anat Histopathol. 1992;421:25–32.PubMedGoogle Scholar
  77. 77.
    Osinga TE, Korpershoek E, de Krijger RR, et al. Catecholamine-synthesizing enzymes are expressed in parasympathetic head and neck paraganglioma tissue. Neuroendocrinology. 2015;101:289–95.PubMedGoogle Scholar
  78. 78.
    Johnson TL, Zarbo RJ, Lloyd RV, Crissman JD. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing. Mod Pathol. 1988;1:216–23.PubMedGoogle Scholar
  79. 79.
    Gill AJ, Benn DE, Chou A, et al. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum Pathol. 2010;41:805–14.PubMedGoogle Scholar
  80. 80.
    van Nederveen FH, Gaal J, Favier J, et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 2009;10:764–71.PubMedPubMedCentralGoogle Scholar
  81. 81.
    Castelblanco E, Santacana M, Valls J, et al. Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas. Endocr Pathol. 2013;24:199–205.PubMedGoogle Scholar
  82. 82.
    Santi R, Rapizzi E, Canu L, et al. Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation. Anticancer Res. 2017;37:805–12.PubMedGoogle Scholar
  83. 83.
    Friedmann DR, Grobelny B, Golfinos JG, Roland JT Jr. Nonschwannoma tumors of the cerebellopontine angle. Otolaryngol Clin N Am. 2015;48:461–75.Google Scholar
  84. 84.
    Tos M, Stangerup SE, Caye-Thomasen P, Tos T, Thomsen J. What is the real incidence of vestibular schwannoma? Arch Otolaryngol Head Neck Surg. 2004;130:216–20.PubMedGoogle Scholar
  85. 85.
    Stangerup SE, Tos M, Thomsen J, Caye-Thomasen P. True incidence of vestibular schwannoma? Neurosurgery. 2010;67:1335–40; discussion 40.PubMedGoogle Scholar
  86. 86.
    Stangerup SE, Caye-Thomasen P. Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin N Am. 2012;45:257–68, vii.Google Scholar
  87. 87.
    Neely JG. Gross and microscopic anatomy of the eighth cranial nerve in relationship to the solitary schwannoma. Laryngoscope. 1981;91:1512–31.PubMedGoogle Scholar
  88. 88.
    Stucken EZ, Brown K, Selesnick SH. Clinical and diagnostic evaluation of acoustic neuromas. Otolaryngol Clin N Am. 2012;45:269–84, vii.Google Scholar
  89. 89.
    de Vries M, van der Mey AG, Hogendoorn PC. Tumor biology of vestibular schwannoma: a review of experimental data on the determinants of tumor genesis and growth characteristics. Otol Neurotol. 2015;36:1128–36.PubMedGoogle Scholar
  90. 90.
    Moffat DA, Irving RM. The molecular genetics of vestibular schwannoma. J Laryngol Otol. 1995;109:381–4.PubMedGoogle Scholar
  91. 91.
    Kishore A, O’Reilly BF. A clinical study of vestibular schwannomas in type 2 neurofibromatosis. Clin Otolaryngol Allied Sci. 2000;25:561–5.PubMedGoogle Scholar
  92. 92.
    Slattery WH. Neurofibromatosis type 2. Otolaryngol Clin N Am. 2015;48:443–60.Google Scholar
  93. 93.
    Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet. 1994;3:885–91.PubMedGoogle Scholar
  94. 94.
    Baser ME. The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene. Hum Mutat. 2006;27:297–306.PubMedGoogle Scholar
  95. 95.
    Irving RM, Harada T, Moffat DA, et al. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma. Am J Otol. 1997;18:754–60.PubMedGoogle Scholar
  96. 96.
    Sriskandan N, Connor SEJ. The role of radiology in the diagnosis and management of vestibular schwannoma. Clin Radiol. 2011;66:357–65.PubMedGoogle Scholar
  97. 97.
    Fusco MR, Fisher WS, McGrew BM, Walters BC. Current practices in vestibular schwannoma management: a survey of American and Canadian neurosurgeons. Clin Neurol Neurosurg. 2014;127:143–8.PubMedGoogle Scholar
  98. 98.
    Carlson ML, Link MJ, Wanna GB, Driscoll CL. Management of sporadic vestibular schwannoma. Otolaryngol Clin N Am. 2015;48:407–22.Google Scholar
  99. 99.
    Thompson LD, Bouffard JP, Sandberg GD, Mena H. Primary ear and temporal bone meningiomas: a clinicopathologic study of 36 cases with a review of the literature. Mod Pathol. 2003;16:236–45.PubMedGoogle Scholar
  100. 100.
    Prayson RA. Middle ear meningiomas. Ann Diagn Pathol. 2000;4:149–53.PubMedGoogle Scholar
  101. 101.
    Stevens KL, Carlson ML, Pelosi S, Haynes DS. Middle ear meningiomas: a case series reviewing the clinical presentation, radiologic features, and contemporary management of a rare temporal bone pathology. Am J Otolaryngol. 2014;35:384–9.PubMedGoogle Scholar
  102. 102.
    Rushing EJ, Bouffard J-P, McCall S, et al. Primary extracranial meningiomas: an analysis of 146 cases. Head Neck Pathol. 2009;3:116–30.PubMedPubMedCentralGoogle Scholar
  103. 103.
    Manski TJ, Heffner DK, Glenn GM, et al. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA. 1997;277:1461–6.PubMedGoogle Scholar
  104. 104.
    Wenig BM, Heffner DK. Endolymphatic sac tumors: fact or fiction? Adv Anat Pathol. 1996;3:378–87.Google Scholar
  105. 105.
    Batsakis JG, el-Naggar AK. Papillary neoplasms (Heffner’s tumors) of the endolymphatic sac. Ann Otol Rhinol Laryngol. 1993;102:648–51.PubMedGoogle Scholar
  106. 106.
    Kupferman ME, Bigelow DC, Carpentieri DF, Bilaniuk LT, Kazahaya K. Endolymphatic sac tumor in a 4-year-old boy. Otol Neurotol. 2004;25:782–6.PubMedGoogle Scholar
  107. 107.
    Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. Cancer. 1989;64:2292–302.PubMedGoogle Scholar
  108. 108.
    Megerian CA, McKenna MJ, Nuss RC, et al. Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope. 1995;105:801–8.PubMedGoogle Scholar
  109. 109.
    Bausch B, Wellner U, Peyre M, et al. Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry. Head Neck. 2016;38 Suppl 1:E673–9.PubMedGoogle Scholar
  110. 110.
    Lonser RR, Kim HJ, Butman JA, Vortmeyer AO, Choo DI, Oldfield EH. Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med. 2004;350:2481–6.PubMedGoogle Scholar
  111. 111.
    Kim HJ, Hagan M, Butman JA, et al. Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications. Laryngoscope. 2013;123:477–83.PubMedGoogle Scholar
  112. 112.
    Kim HJ, Butman JA, Brewer C, et al. Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment. J Neurosurg. 2005;102:503–12.PubMedGoogle Scholar
  113. 113.
    Kawahara N, Kume H, Ueki K, Mishima K, Sasaki T, Kirino T. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease. Neurology. 1999;53:208–10.PubMedGoogle Scholar
  114. 114.
    Jensen RL, Gillespie D, House P, Layfield L, Shelton C. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. J Neurosurg. 2004;100:488–97.PubMedGoogle Scholar
  115. 115.
    Bambakidis NC, Rodrigue T, Megerian CA, Ratcheson RA. Endolymphatic sac tumor metastatic to the spine. Case report. J Neurosurg Spine. 2005;3:68–70.PubMedGoogle Scholar
  116. 116.
    Tay KY, Yu E, Kassel E. Spinal metastasis from endolymphatic sac tumor. Am J Neuroradiol. 2007;28:613–4.PubMedGoogle Scholar
  117. 117.
    Bambakidis NC, Megerian CA, Ratcheson RA. Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status. Otol Neurotol. 2004;25:773–81.PubMedGoogle Scholar
  118. 118.
    Bell D, Gidley P, Levine N, Fuller GN. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience. Ann Diagn Pathol. 2011;15:117–23.PubMedGoogle Scholar
  119. 119.
    Binderup ML, Bisgaard ML, Harbud V, et al. Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition. Dan Med J. 2013;60:B4763.PubMedGoogle Scholar
  120. 120.
    Thompson LD, Magliocca K, Stelow E, Wenig BM, Bishop JA. CAIX and PAX8 are commonly immunoreactive in endolymphatic sac tumors: differential with renal cell carcinoma in von-Hippel-Lindau patients. Mod Pathol. 2018.Google Scholar
  121. 121.
    Sandison A. Aggressive papillary tumour. In: El-Naggar AKCJ, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC Press; 2017. p. 266–7.Google Scholar
  122. 122.
    Tysome JR, Harcourt J, Patel MC, Sandison A, Michaels L. Aggressive papillary tumor of the middle ear: a true entity or an endolymphatic sac neoplasm? Ear Nose Throat J. 2008;87:378–93.PubMedGoogle Scholar
  123. 123.
    Gaffey MJ, Mills SE, Boyd JC. Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel-Lindau disease. Am J Surg Pathol. 1994;18:1254–60.PubMedGoogle Scholar
  124. 124.
    Kawabata S, Christine Hollander M, Munasinghe JP, et al. Epidermal growth factor receptor as a novel molecular target for aggressive papillary tumors in the middle ear and temporal bone. Oncotarget. 2015;6:11357–68.PubMedPubMedCentralGoogle Scholar
  125. 125.
    Gaffey MJ, Mills SE, Fechner RE, Intemann SR, Wick MR. Aggressive papillary middle-ear tumor. A clinicopathologic entity distinct from middle-ear adenoma. Am J Surg Pathol. 1988;12:790–7.PubMedGoogle Scholar
  126. 126.
    Wenig BM. Schneiderian-type mucosal papillomas of the middle ear and mastoid. Ann Otol Rhinol Laryngol. 1996;105:226–33.PubMedGoogle Scholar
  127. 127.
    Jang CH, Choi HS, Hong YS, Cho YB. Cavernous hemangioma of the tympanic membrane. Clin Exp Otorhinolaryngol. 2011;4:109–11.PubMedPubMedCentralGoogle Scholar
  128. 128.
    Pistorio V, Stefano A, Petrucci AG, Achilli V. Capillary haemangioma of the middle ear: a rare lesion difficult to evaluate. Acta Otorhinolaryngol Ital. 2011;31:109–12.PubMedGoogle Scholar
  129. 129.
    Salamat AA, Casselden E, Theaker J, Batty V, Thomas S. Middle ear capillary haemangioma: review of literature and appraisal of management options. Auris Nasus Larynx. 2016;43:595–601.PubMedGoogle Scholar
  130. 130.
    Greinwald JH Jr, Lassen LF. Lipomas of the internal auditory canal. Laryngoscope. 1997;107:364–8.PubMedGoogle Scholar
  131. 131.
    Saunders JE, Kwartler JA, Wolf HK, Brackmann DE, McElveen JT Jr. Lipomas of the internal auditory canal. Laryngoscope. 1991;101:1031–7.PubMedGoogle Scholar
  132. 132.
    Marie B, Baylac F, Coffinet L, Simon C, Pialoux A, Vignaud JM. [Lipoma of the internal auditory canal. Report of two cases simulating acoustic neuroma]Ann Pathol. 1998;18:52–4.PubMedGoogle Scholar
  133. 133.
    Singh RK, Goyal A, Kumar A, Kataria G, Kesarwani A. Mastoid osteoma of temporal bone – a rare case report. J Clin Diagn Res. 2017;11:MD01–MD2.PubMedPubMedCentralGoogle Scholar
  134. 134.
    Gungor A, Cincik H, Poyrazoglu E, Saglam O, Candan H. Mastoid osteomas: report of two cases. Otol Neurotol. 2004;25:95–7.PubMedGoogle Scholar
  135. 135.
    Denia A, Perez F, Canalis RR, Graham MD. Extracanalicular osteomas of the temporal bone. Arch Otolaryngol. 1979;105:706–9.PubMedGoogle Scholar
  136. 136.
    Pérez-Mora RM, Sanchez-Carrion S, Barea FL, Garcia-Raya P, Lassaletta L. Osteoblastoma of the temporal bone. Skull Base. 2009;19:345–8.PubMedPubMedCentralGoogle Scholar
  137. 137.
    Doshi SV, Frantz TD, Korol HW. Benign osteoblastoma of the temporal bone: case report and literature review. Am J Otolaryngol. 2001;22:211–4.PubMedGoogle Scholar
  138. 138.
    Bertoni F, Unni KK, Beabout JW, Harner SG, Dahlin DC. Chondroblastoma of the skull and facial bones. Am J Clin Pathol. 1987;88:1–9.PubMedGoogle Scholar
  139. 139.
    Silverstein H, Griffin WL Jr, Balogh K Jr. Teratoma of the middle ear and mastoid process. A case with aberrant innervation of the facial musculature. Arch Otolaryngol. 1967;85:243–8.PubMedGoogle Scholar
  140. 140.
    Kenyon GS, Marks PV, Scholtz CL, Dhillon R. Squamous cell carcinoma of the middle ear. A 25-year retrospective study. Ann Otol Rhinol Laryngol. 1985;94:273–7.PubMedGoogle Scholar
  141. 141.
    Durve DV, Kanegaonkar RG, Albert D, Levitt G. Paediatric rhabdomyosarcoma of the ear and temporal bone. Clin Otolaryngol Allied Sci. 2004;29:32–7.PubMedGoogle Scholar
  142. 142.
    Dehner LP, Chen KT. Primary tumors of the external and middle ear. III. A clinicopathologic study of embryonal rhabdomyosarcoma. Arch Otolaryngol. 1978;104:399–403.PubMedGoogle Scholar
  143. 143.
    Nora FE, Unni KK, Pritchard DJ, Dahlin DC. Osteosarcoma of extragnathic craniofacial bones. Mayo Clin Proc. 1983;58:268–72.PubMedGoogle Scholar
  144. 144.
    Huvos AG, Sundaresan N, Bretsky SS, Butler A. Osteogenic sarcoma of the skull. A clinicopathologic study of 19 patients. Cancer. 1985;56:1214–21.PubMedGoogle Scholar
  145. 145.
    Coltrera MD, Googe PB, Harrist TJ, Hyams VJ, Schiller AL, Goodman ML. Chondrosarcoma of the temporal bone. Diagnosis and treatment of 13 cases and review of the literature. Cancer. 1986;58:2689–96.PubMedGoogle Scholar
  146. 146.
    Yagisawa M, Ishitoya J, Tsukuda M, Sakagami M. Chondrosarcoma of the temporal bone. Auris Nasus Larynx. 2007;34:527–31.PubMedGoogle Scholar
  147. 147.
    Kandiloros DC, Nikolopoulos TP, Ferekidis EA, Kaloterakis AN, Papadimitriou CP, Adamopoulos GK. Primary extramedullary plasmacytoma in the middle ear: differential diagnosis and management. J Laryngol Otol. 1994;108:868–70.PubMedGoogle Scholar
  148. 148.
    Lang EE, Walsh RM, Leader M. Primary middle-ear lymphoma in a child. J Laryngol Otol. 2003;117:205–7.PubMedGoogle Scholar
  149. 149.
    Li B, Liu S, Yang H, Wang W. Primary T-cell lymphoblastic lymphoma in the middle ear. Int J Pediatr Otorhinolaryngol. 2016;82:19–22.PubMedGoogle Scholar
  150. 150.
    Maithrea N, Periyathamby S, Mohamad I. Primary Hodgkin’s lymphoma of the middle ear: a rare cause of facial nerve palsy. Egypt J Ear Nose Throat Allied Sci. 2017;18:67–9.Google Scholar
  151. 151.
    Markou K, Karasmanis I, Goudakos JK, Papaioannou M, Psifidis A, Vital V. Extramedullary plasmacytoma of temporal bone: report of 2 cases and review of literature. Am J Otolaryngol. 2009;30:360–5.PubMedGoogle Scholar
  152. 152.
    Appling D, Jenkins HA, Patton GA. Eosinophilic granuloma in the temporal bone and skull. Otolaryngol Head Neck Surg. 1983;91:358–65.PubMedGoogle Scholar
  153. 153.
    al-Ammar AY, Tewfik TL, Bond M, Schloss MD. Langerhans’ cell histiocytosis: paediatric head and neck study. J Otolaryngol. 1999;28:266–72.PubMedGoogle Scholar
  154. 154.
    Cochrane LA, Prince M, Clarke K. Langerhans’ cell histiocytosis in the paediatric population: presentation and treatment of head and neck manifestations. J Otolaryngol. 2003;32:33–7.PubMedGoogle Scholar
  155. 155.
    Fernandez-Latorre F, Menor-Serrano F, Alonso-Charterina S, Arenas-Jimenez J. Langerhans’ cell histiocytosis of the temporal bone in pediatric patients: imaging and follow-up. AJR Am J Roentgenol. 2000;174:217–21.PubMedGoogle Scholar
  156. 156.
    Ginat DT, Johnson DN, Cipriani NA. Langerhans cell histiocytosis of the temporal bone. Head Neck Pathol. 2016;10:209–12.PubMedGoogle Scholar
  157. 157.
    Davis GL. Secondary tumours. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours pathology & genetics head and neck tumours. 3rd ed. Lyon: IARC Press; 2005. p. 360.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Moffitt Cancer Center, Anatomic Pathology, University of South FloridaTampaUSA

Personalised recommendations